MilliporeSigma

Belkins
At MilliporeSigma, one of the top three investors in R&D in the Life Science Tools industry, we develop cutting-edge technologies and services for bioscience research and biopharmaceutical manufacturing. Innovation drives everything we do. And it’s reinforced by our collaborative culture, pioneering spirit and unwavering focus on the world’s most challenging human health issues.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

MERCK ANNOUNCES EMERGING BIOTECH GRANT PROGRAM WINNERS

MilliporeSigma | January 23, 2017

news image

Merck, a leading science and technology company, today announced the winners of its Emerging Biotech Grant Program in Europe. Applicants from emerging biotechnology companies across Europe were asked to describe one or more of their current projects, the medical needs they solve and process development challenges they face to be considered for the grant....

Read More

MERCK OPENS PRODUCTION FACILITY EXCLUSIVELY FOR MEGLUMINE IN SPAIN

MilliporeSigma | January 17, 2017

news image

Merck, a leading science and technology company, today announced the opening of a facility in Mollet des Vallès, Spain dedicated to the manufacture of meglumine, an FDA-approved excipient for pharmaceuticals and a component of medical imaging contrast media....

Read More

MERCK EXPANDS END-TO-END BIODEVELOPMENT CENTERS IN NORTH AMERICA, CHINA AND EUROPE

MilliporeSigma | January 10, 2017

news image

Merck, a leading science and technology company, today announced the expansion of its end-to-end biodevelopment centers to meet increasing customer demand for its turnkey portfolio of bioprocessing products, manufacturing capabilities and industry leading technological expertise....

Read More

MERCK ACQUIRES BIOCONTROL TO STRENGTHEN POSITION IN FOOD SAFETY TESTING

MilliporeSigma | January 04, 2017

news image

Merck, a leading life science and technology company, today announced it has acquired BioControl Systems Inc., a global leader in food safety testing. The acquisition opens growth opportunities for Merck in the food and beverage space; particularly in the U.S. Confidentiality has been agreed on the financial details of the transaction....

Read More
news image

MERCK ANNOUNCES EMERGING BIOTECH GRANT PROGRAM WINNERS

MilliporeSigma | January 23, 2017

Merck, a leading science and technology company, today announced the winners of its Emerging Biotech Grant Program in Europe. Applicants from emerging biotechnology companies across Europe were asked to describe one or more of their current projects, the medical needs they solve and process development challenges they face to be considered for the grant....

Read More
news image

MERCK OPENS PRODUCTION FACILITY EXCLUSIVELY FOR MEGLUMINE IN SPAIN

MilliporeSigma | January 17, 2017

Merck, a leading science and technology company, today announced the opening of a facility in Mollet des Vallès, Spain dedicated to the manufacture of meglumine, an FDA-approved excipient for pharmaceuticals and a component of medical imaging contrast media....

Read More
news image

MERCK EXPANDS END-TO-END BIODEVELOPMENT CENTERS IN NORTH AMERICA, CHINA AND EUROPE

MilliporeSigma | January 10, 2017

Merck, a leading science and technology company, today announced the expansion of its end-to-end biodevelopment centers to meet increasing customer demand for its turnkey portfolio of bioprocessing products, manufacturing capabilities and industry leading technological expertise....

Read More
news image

MERCK ACQUIRES BIOCONTROL TO STRENGTHEN POSITION IN FOOD SAFETY TESTING

MilliporeSigma | January 04, 2017

Merck, a leading life science and technology company, today announced it has acquired BioControl Systems Inc., a global leader in food safety testing. The acquisition opens growth opportunities for Merck in the food and beverage space; particularly in the U.S. Confidentiality has been agreed on the financial details of the transaction....

Read More